by Combat Cancer | Jan 28, 2024 | News
The Medical Innovators Interview with Professor Shingai Mutambirwa Sequencing the Black African genome, the urologist shortage in Africa, and making friends with cancer… It’s all in our new Medical Innovators interview, with Combat’s Guy Cooper in conversation...
by Combat Cancer | Jan 27, 2024 | News
RC is recommended for patients with non-muscle-invasive bladder cancer for whom BCG immunotherapy has failed – that’s around 50% of high-risk cases. However, many patients are unwilling to undergo RC because of its impact on quality of life. While bladder cancer...
by Combat Cancer | Jan 19, 2024 | News
Bladder cancer is among the most common types of cancer, with varying degrees of invasiveness. Non-muscle-invasive bladder cancer (NMIBC) is a subtype where cancer cells are confined to the surface layers of the bladder wall and have not invaded the muscle layer. This...
by Combat Cancer | Jan 11, 2024 | News
Shaping the Future of Bladder Cancer Care Hosted by MEP Isátv Ujhelyi, a momentous policy roundtable was convened on 25 September 2023, where the white paper’s recommendations were unveiled. The discussion was centred around identifying legislative opportunities...
Recent Comments